Skip to main content

Peer Review reports

From: Safety and preliminary efficacy data of a novel Casein Kinase 2 (CK2) peptide inhibitor administered intralesionally at four dose levels in patients with cervical malignancies

Original Submission
14 Oct 2008 Submitted Original manuscript
5 Dec 2008 Reviewed Reviewer Report - Hitoshi Tsuda
22 Dec 2008 Reviewed Reviewer Report - Perry Grigsby
8 Jan 2009 Reviewed Reviewer Report - Cicek Gercel-Taylor
8 Jan 2009 Reviewed Reviewer Report - Khalil Ahmed
21 Feb 2009 Author responded Author comments - Silvio E Perea
Resubmission - Version 2
21 Feb 2009 Submitted Manuscript version 2
27 Feb 2009 Reviewed Reviewer Report - Khalil Ahmed
17 Mar 2009 Reviewed Reviewer Report - Cicek Gercel-Taylor
30 Mar 2009 Author responded Author comments - Silvio E Perea
Resubmission - Version 3
30 Mar 2009 Submitted Manuscript version 3
21 Apr 2009 Author responded Author comments - Silvio E Perea
Resubmission - Version 4
21 Apr 2009 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
11 May 2009 Author responded Author comments - Silvio E Perea
Resubmission - Version 6
11 May 2009 Submitted Manuscript version 6
Publishing
13 May 2009 Editorially accepted
13 May 2009 Article published 10.1186/1471-2407-9-146

You can find further information about peer review here.

Back to article page